Latest Networking News

Nexsen is pursuing a second Group B Streptococcus device through a proposed FlashDx joint venture while upgrading StrepSure after interim clinical data shifted its US FDA submission target to early 2027. The diagnostics developer ended September with $3.56 million in cash, equivalent to about four quarters of funding at the latest operating cash-flow rate.

SiteMinder is targeting mid-20s annual recurring revenue growth through FY30 and an adjusted EBITDA margin in the mid-20s, as it positions its hotel commerce platform for an AI-led shift in bookings and revenue management. The company entered that plan after FY26 revenue reached A$266 million and adjusted EBITDA margin rose to 10.6%.

Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.

Singular Health has moved closer to a proposed A$3.5 million Florida Medicaid imaging repository while deploying 1,000 physician licences through its largest customer network. The September quarter also exposed the execution risks ahead, with the Florida MOU still subject to definitive agreements and the PNS contract due for renewal by year-end.

Fleetwood enters FY27 with a stronger Community Solutions business, a $61.5 million net cash position and a plan to restore Building Solutions to profitability in the second half. The key tests are completing the Red Dog Village acquisition and proving its manufacturing reset can overcome a $8.7 million underlying loss.

Swoop ended Q1 FY27 with $5.9 million in cash after a $2.0 million operating outflow, but is progressing two conditional fibre asset sales worth about $15.5 million. The TPG mobile migration also produced less customer churn than expected, giving the challenger telco some operational momentum as it works to reduce debt.

Euroz Hartleys Group delivered a sharp FY26 earnings recovery as revenue rose 43.6% and net profit increased 62.4%, while its $145 million sale of Capital Markets to BMO moved towards completion. The transaction will leave the ASX-listed group focused on Private Wealth, with a strategic question hanging over how much earnings power survives the separation.

Lumos Diagnostics has expanded FebriDx deployment to 265 US healthcare sites across 29 states, while product revenue rose 224% in the first quarter. The commercial gains came alongside a US$4.7 million operating cash outflow, slower-than-planned paediatric study enrolment and a Hologic development timeline pushed to around June 2028.

Resonance Health has secured an oversubscribed $6.0 million placement to fund MRI endpoint expansion, new TrialsWest sites and development of its non-invasive liver fibrosis device. The raise lifts pro forma net cash to $7.9 million, but the most consequential project remains an investigational technology backed by a small preliminary dataset.

Universal Store has opened FY27 with 9.3% growth in direct-to-customer sales, led by a sharp lift from Perfect Stranger. The retailer is maintaining its plan for 16 to 20 new stores despite continued weakness in CTC’s wholesale channel.

IDP Education has reaffirmed FY27 Adjusted EBIT guidance of A$95 million to A$115 million after using cost control, stronger yields and cash generation to cushion another sharp fall in international student volumes. The AGM also disclosed that the board had rejected an unsolicited acquisition proposal and had completed about A$11 million of a planned A$50 million buyback.

SCX.ai has reported positive operating cash flow in its first quarter as an ASX-listed company, alongside a 54% increase in annualised recurring revenue since its prospectus. The sovereign AI infrastructure provider also has more than 100 commercial customers and $23.9 million in cash, but its next test is converting new capacity and partnerships into durable revenue.